An FDA advisory panel voted on Friday to reject a plan to offer a third Pfizer COVID-19 shot to most Americans. Newsday's Steve Langford reports. Credit: Newsday / Reece Williams/Reece Williams

SUBSCRIBE

Unlimited Digital AccessOnly 25¢for 6 months

ACT NOWSALE ENDS SOON | CANCEL ANYTIME